Aeglea Biotherapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $662k | 40k | 16.76 |
| 2025-06-30 | $1.3M | 86k | 14.97 |
| 2025-03-31 | $841k | 52k | 16.14 |
| 2024-12-31 | $1.1M | 49k | 23.28 |
| 2024-09-30 | $778k | 26k | 29.41 |
| 2024-06-30 | $708k | 30k | 23.51 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas